| Phrase | Consultant | Town | Special Interests |
| clinical research in clinical trials - phase 1 | *Consultant(s)* | *Towns* | Medical oncology, melanoma, clinical research in clinical trials - phase 1, urological oncology |
| core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma | *Consultant(s)* | *Towns* | Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery |
| development of early phase clinical trials of anti-cancer therapies | *Consultant(s)* | *Towns* | Medical oncology, development of early phase clinical trials of anti-cancer therapies |
| early phase clinical trials | *Consultant(s)* | *Towns* | Medical oncology, pancreatic cancer, gastrointestinal cancer, neuroendocrine tumours, early phase clinical trials |
| early phase clinical trials | *Consultant(s)* | *Towns* | Paediatric neuro-oncology, neuroblastoma, early phase clinical trials |
| early phase clinical trials | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal cancer, endocrine cancer, hepatobiliary tumours, early phase clinical trials |
| Early phase clinical trials | *Consultant(s)* | *Towns* | Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery |
| early phase clinical trials | *Consultant(s)* | *Towns* | Medical oncology, drug development, ovarian cancer, endometrial cancer, cervical cancer, early phase clinical trials |
| early phase clinical trials | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, head and neck cancer, early phase clinical trials, immunotherapy |
| early phase clinical trials | *Consultant(s)* | *Towns* | Medical oncology, metastatic melanoma, early phase clinical trials |
| early phase trials | *Consultant(s)* | *Towns* | Medical oncology, thoracic oncology, lung cancer, early phase trials |
| early phase trials for childhood leukaemia | *Consultant(s)* | *Towns* | Paediatric oncology, childhood leukaemia and lymphoma, early phase trials for childhood leukaemia |
| Lead Undergraduate Medical Students Phase 3a Obstetrics and Gynaecology | *Consultant(s)* | *Towns* | Fertility, recurrent miscarriage, polycystic ovary syndrome - PCOS, Lead Undergraduate Medical Students Phase 3a Obstetrics and Gynaecology |
| phase 1 - 2 trials | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, cancer drug development, phase 1 - 2 trials |
| phase 1 drug development | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, head and neck cancer, phase 1 drug development |
| phase 1 trials | *Consultant(s)* | *Towns* | Medical oncology, melanoma, liver cancer, inoperable cancer, phase 1 trials, upper gastrointestinal cancers |
